Once-weekly injection for type 2 diabetes controlled by diet and exercise
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests a new medicine called RAY1225, given as a once-weekly injection, to help lower blood sugar in adults with type 2 diabetes. It is for people who have not been on diabetes medications recently or have only taken oral medications before, and who have not started insulin.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have type 2 diabetes.
- You must not have taken any diabetes pills or other diabetes medications for at least 12 weeks before the study (or never taken any diabetes medications).
- If you have taken diabetes pills before, you must have taken no more than two different pills at the same time.
- Your body mass index (BMI) must be 20 or higher at the screening visit.
- Your weight must have been stable (no more than 5% change) for the past 12 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two injectable medications, RAY1225 and semaglutide, added to your usual diabetes pills, to see how well they control blood sugar and affect weight. It aims to help improve glucose control in people with type 2 diabetes.
This study tests a new medication called HM15275 to help control blood sugar in people with type 2 diabetes. The trial will check if the medication works well and is safe when added to diet, exercise, or metformin treatment.
This study tests a once-weekly injection (HDM1005) to see if it improves blood sugar control in people with type 2 diabetes who are already taking metformin alone or with an SGLT2 inhibitor. It may help lower your A1C levels and manage your weight.
This study tests a new once-weekly injectable medication (HDM1005) for people with type 2 diabetes whose blood sugar is not well controlled by diet and exercise or metformin alone. It aims to help lower blood sugar and may also support weight loss.
This trial tests a new medicine called HDM1005 for people with type 2 diabetes who haven't been helped enough by diet and exercise alone, and who haven't taken any diabetes medication in the last 12 weeks. It aims to see if the medicine can help lower blood sugar levels safely.
This study tests an investigational injectable medicine (IN-B00009) to see how well it controls blood sugar in adults with type 2 diabetes that is not well managed by diet and exercise alone. If you qualify, you may receive the study drug and will be monitored closely to see if it helps lower your blood sugar safely.
Hear when a new T2DM trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.